Clinical Trials Browser

Phase 1 × Glioblastoma × lutetium Lu 177 dotatate × Clear all

NCT05109728 2026-05-22

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Phase 1 Active not recruiting

Glioblastoma